181 related articles for article (PubMed ID: 33499706)
1. Application of machine learning-based models to boost the predictive power of the SPAN index.
Chung CC; Bamodu OA; Hong CT; Chan L; Chiu HW
Int J Neurosci; 2023 Jan; 133(1):26-36. PubMed ID: 33499706
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of stroke prognostication using age and NIH Stroke Scale index (SPAN-100 index) in delayed intravenous thrombolysis patients (beyond 4.5 hours).
Elsaid N; Bigliardi G; Dell'Acqua ML; Vandelli L; Ciolli L; Picchetto L; Borzì G; Ricceri R; Pentore R; Vallone S; Meletti S; Saied A
J Stroke Cerebrovasc Dis; 2022 Apr; 31(4):106384. PubMed ID: 35182948
[TBL] [Abstract][Full Text] [Related]
3. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
[TBL] [Abstract][Full Text] [Related]
4. [Establishment and evaluation of a predictive model for early neurological deterioration after intravenous thrombolysis in acute ischemic stroke based on machine learning].
Lyu Z; Yang H; Wang Y; Chen X; Zhang C; Wang W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Sep; 35(9):945-950. PubMed ID: 37803953
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Clinical Outcome in Patients with Large-Vessel Acute Ischemic Stroke: Performance of Machine Learning versus SPAN-100.
Jiang B; Zhu G; Xie Y; Heit JJ; Chen H; Li Y; Ding V; Eskandari A; Michel P; Zaharchuk G; Wintermark M
AJNR Am J Neuroradiol; 2021 Jan; 42(2):240-246. PubMed ID: 33414230
[TBL] [Abstract][Full Text] [Related]
6. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
Masrur S; Abdullah AR; Smith EE; Hidalgo R; El-Ghandour A; Rordorf G; Schwamm LH
J Stroke Cerebrovasc Dis; 2011; 20(2):124-30. PubMed ID: 20598579
[TBL] [Abstract][Full Text] [Related]
7. A weakly supervised deep learning model integrating noncontrasted computed tomography images and clinical factors facilitates haemorrhagic transformation prediction after intravenous thrombolysis in acute ischaemic stroke patients.
Ru X; Zhao S; Chen W; Wu J; Yu R; Wang D; Dong M; Wu Q; Peng D; Song Y
Biomed Eng Online; 2023 Dec; 22(1):129. PubMed ID: 38115029
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
[TBL] [Abstract][Full Text] [Related]
9. Safety Outcomes After Thrombolysis for Acute Ischemic Stroke in Patients With Recent Stroke.
Merkler AE; Salehi Omran S; Gialdini G; Lerario MP; Yaghi S; Elkind MSV; Navi BB
Stroke; 2017 Aug; 48(8):2282-2284. PubMed ID: 28679847
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study.
Wang X; Li X; Xu Y; Li R; Yang Q; Zhao Y; Wang F; Sheng B; Wang R; Chen S; Wang L; Shen L; Hou X; Cui Y; Wang D; Peng B; Anderson CS; Chen H;
Stroke Vasc Neurol; 2021 Dec; 6(4):603-609. PubMed ID: 33903179
[TBL] [Abstract][Full Text] [Related]
11. A simple risk index and thrombolytic treatment response in acute ischemic stroke.
Ovbiagele B; Reeves MJ; Nasiri M; Johnston SC; Bath PM; Saposnik G;
JAMA Neurol; 2014 Jul; 71(7):848-54. PubMed ID: 24798141
[TBL] [Abstract][Full Text] [Related]
12. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
[TBL] [Abstract][Full Text] [Related]
13. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C is a potential predictor of unfavorable outcomes for cerebral ischemia with intravenous tissue plasminogen activator treatment: A multicenter prospective nested case-control study.
Chang Z; Zou H; Xie Z; Deng B; Que R; Huang Z; Weng G; Wu Z; Pan Y; Wang Y; Li M; Xie H; Zhu S; Xiong L; Ct Mok V; Jin K; Yenari MA; Wei X; Wang Q
Eur J Neurol; 2021 Apr; 28(4):1265-1274. PubMed ID: 33277774
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the safety and efficacy of intravenous thrombolysis for acute ischemic stroke patients with a history of intracerebral hemorrhage: a systematic review and meta-analysis.
Goh S; Tan NHW; Tan CH; Leow AST; Sia CH; Ho AFW; Lim MJR; Yeo LLL; Tan BYQ
J Thromb Thrombolysis; 2022 Feb; 53(2):485-494. PubMed ID: 34302590
[TBL] [Abstract][Full Text] [Related]
16. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
[TBL] [Abstract][Full Text] [Related]
17. Timing of recanalization after intravenous thrombolysis and functional outcomes after acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Liang S; Venketasubramanian N; Rathakrishnan R; Ahmad A; Ng KW; Loh PK; Ong JJ; Wakerley BR; Chong VF; Bathla G; Sharma VK
JAMA Neurol; 2013 Mar; 70(3):353-8. PubMed ID: 23599933
[TBL] [Abstract][Full Text] [Related]
18. Association between different acute stroke therapies and development of post stroke seizures.
Naylor J; Thevathasan A; Churilov L; Guo R; Xiong Y; Koome M; Chen Z; Chen Z; Liu X; Kwan P; Campbell BCV
BMC Neurol; 2018 May; 18(1):61. PubMed ID: 29724190
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
[TBL] [Abstract][Full Text] [Related]
20. Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort Study.
Chen Z; Xu C; Zhong W; Gong X; Hu H; Zhang X; Chen Y; Li Q; Luo Z; Chen Z; Lou M
Transl Stroke Res; 2021 Aug; 12(4):530-539. PubMed ID: 32895894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
